ZTS ZTS ゾエティス

 ZTSのチャート


 ZTSの企業情報

symbol ZTS
会社名 Zoetis Inc (ZTS ゾエティス)
分野(sector)   
産業(industry)   
業種 医薬品   医療関連(Health Care)
概要 事業概要 ゾエティス(Zoetis Inc)は家畜・ペットを中心とする動物用医薬品とワクチンの発見・開発・生産・商品化に従事する。同社は牛、豚、鶏、羊、魚、犬、猫、馬という8種類の動物を販売して、抗感染症薬、ワクチン、寄生虫駆除剤、薬用飼料添加物と他の医薬品という5種類の製品を提供する。同社の事業は米国と国際を含む。同社は家畜・ペット顧客に製品ポートフォリオを提供する。家畜製品はセファオフル注射ライン、Draxxin、Spectramast、Bovi-Shieldライン、Rispovalライン、SuvaxynまたはFosters、Embrexデバイス、Lutalyseを含む。ペット製品はClavamoxまたはSynulox、Convenia、ProHeart、RevolutionまたはStronghold、Apoquel、Cerenia、Rimadylを含む。  ゾエティスは米国の大手アニマルヘルス関連企業。家畜やペットを中心に動物向けの薬やワクチンの発見、開発、製造、販売に従事。生産拠点や販売網は世界各地に広がる。主要製品は、抗感染症薬、ワクチン、寄生虫用薬剤、薬用飼料添加物、鎮静剤、抗がん剤や制吐剤など。また診断、遺伝学、酪農デ―タ管理、コンサルティングなども提供。本社はニュ―ジャ―ジ―州。  zoetis is a global animal health company dedicated to supporting customers and their businesses in ever better ways. building on 60 years of experience, we deliver quality medicines and vaccines, complemented by diagnostic products, genetic tests, biodevices and a range of services. we are working every day to better understand and address the real-world challenges faced by those who raise and care for animals. our name, zoetis (zō-eh-tis), has its root in zo, familiar in words such as zoo and zoology and derived from zoetic, meaning “pertaining to life.” it signals our company’s dedication to supporting the veterinarians and livestock producers everywhere who raise and care for the farm and companion animals on which we all depend.
本社所在地 973 822-7000
代表者氏名 Juan Ramon Alaix
代表者役職名 Chief Executive Officer Director
電話番号 +1 973-822-7000
設立年月日 41091
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 10000人
url www.zoetis.com
nasdaq_url
adr_tso
EBITDA EBITDA(百万ドル) 2246.00000
終値(lastsale)
時価総額(marketcap)
時価総額 時価総額(百万ドル) 48197.97000
売上高 売上高(百万ドル) 5825.00000
企業価値(EV) 企業価値(EV)(百万ドル) 52948.97000
当期純利益 当期純利益(百万ドル) 1383.00000
決算概要 決算概要 BRIEF: For the fiscal year ended 31 December 2018 Zoetis Inc revenues increased 10% to $5.83B. Net income before extraordinary items increased 29% to $1.38B. Revenues reflect US segment increase of 10% to $2.88B International segment increase of 9% to $2.89B The United States (U.S.) segment increase of 10% to $2.88B International segment increase of 9% to $2.89B.

 ZTSのテクニカル分析


 ZTSのニュース

   3 Ways to Play the Ongoing Demand for Farmland  2023/05/31 19:51:30 InvestorPlace
Despite cooling inflation , investing in farmland remains an excellent way to hedge against higher prices. That’s because it’s a real asset that does well in periods of inflation and over more extended periods because of ongoing food scarcity issues. According to Barron’s reporting , the 25-year average annual return for farmland through March 2021 was 11.2%, 160 basis points higher than the S&P 500 . As they say about land, “They’re not making it anymore.” And, in the case of farmland, it’s shrinking every year. For example, between 2002 and 2022, approximately 11 million acres were lost to development in the U.S. Add in the amount of food that will need to be produced in the next 30 years to meet the growing global population and it seems unlikely that farmland will lose much of its value. Demand and increasing scarcity are a recipe for higher prices. One of the easiest farmland investment strategies involves buying stocks in agriculture-related businesses such as combine and tractor makers.
   $1000 Invested In This Stock 10 Years Ago Would Be Worth $5,000 Today  2023/05/29 19:30:55 Benzinga
Zoetis (NYSE: ZTS ) has outperformed the market over the past 10 years by 7.77% on an annualized basis producing an average annual return of 17.66%. Currently, Zoetis has a market capitalization of $76.13 billion. Buying $1000 In ZTS: If an … Full story available on Benzinga.com
   Zoetis analyst day ''modestly underperformed'' - Goldman Sachs  2023/05/26 18:38:00 Investing.com
https://www.investing.com/news/stock-market-news/zoetis-analyst-day-modestly-underperformed--goldman-sachs-432SI-3092294
   Zoetis Holds Investor Day and Presents Strategy to Shape Animal Health for the Next Decade  2023/05/25 11:30:00 Wallstreet:Online
Zoetis Inc. (NYSE:ZTS) is hosting an investor day at 9:00 a.m. ET today at the New York Stock Exchange, where the company will dive into its compelling growth ambitions, its innovative and robust R&D pipeline and its financial roadmap to continue delivering shareholder value, as it Shapes Animal Health for the Next Decade. During today’s presentations, Chief Executive Officer Kristin Peck,
   Zoetis Declares New Dividend, Hinting At Undervaluation  2023/05/19 16:51:36 Benzinga
Zoetis (NYSE: ZTS ) shareholders may have a new reference point to be excited about, even after witnessing some favorable developments through the company''s first quarter 2023 announcements. Even after outperforming other peers in the sector, such as Bausch Health Companies (NYSE: BHC ) and Elanco Animal Health (NYSE: ELAN ) by as much as 32% and 75%, respectively, analyst ratings still suggest that Zoetis stock has a double-digit upside potential ceiling from today''s prices. News has broken out regarding JAB''s acquisition of the pet insurance platform Pumpkin. In an attempt to expand its global leadership in the pet insurance industry, JAB''s acquisition indirectly benefitted Zoetis, which still is looking to maintain its minority interest in the platform. A continued commercial partnership and financial interests will no doubt accrue to Zoetis'' financials moving forward. While the transaction terms have not been disclosed, some analysts can derive some valuation given the sixty-five thousand pets insured since Pumpkin''s launch in 2020.
   3 Ways to Play the Ongoing Demand for Farmland  2023/05/31 19:51:30 InvestorPlace
Despite cooling inflation , investing in farmland remains an excellent way to hedge against higher prices. That’s because it’s a real asset that does well in periods of inflation and over more extended periods because of ongoing food scarcity issues. According to Barron’s reporting , the 25-year average annual return for farmland through March 2021 was 11.2%, 160 basis points higher than the S&P 500 . As they say about land, “They’re not making it anymore.” And, in the case of farmland, it’s shrinking every year. For example, between 2002 and 2022, approximately 11 million acres were lost to development in the U.S. Add in the amount of food that will need to be produced in the next 30 years to meet the growing global population and it seems unlikely that farmland will lose much of its value. Demand and increasing scarcity are a recipe for higher prices. One of the easiest farmland investment strategies involves buying stocks in agriculture-related businesses such as combine and tractor makers.
   $1000 Invested In This Stock 10 Years Ago Would Be Worth $5,000 Today  2023/05/29 19:30:55 Benzinga
Zoetis (NYSE: ZTS ) has outperformed the market over the past 10 years by 7.77% on an annualized basis producing an average annual return of 17.66%. Currently, Zoetis has a market capitalization of $76.13 billion. Buying $1000 In ZTS: If an … Full story available on Benzinga.com
   Zoetis analyst day ''modestly underperformed'' - Goldman Sachs  2023/05/26 18:38:00 Investing.com
https://www.investing.com/news/stock-market-news/zoetis-analyst-day-modestly-underperformed--goldman-sachs-432SI-3092294
   Zoetis Holds Investor Day and Presents Strategy to Shape Animal Health for the Next Decade  2023/05/25 11:30:00 Wallstreet:Online
Zoetis Inc. (NYSE:ZTS) is hosting an investor day at 9:00 a.m. ET today at the New York Stock Exchange, where the company will dive into its compelling growth ambitions, its innovative and robust R&D pipeline and its financial roadmap to continue delivering shareholder value, as it Shapes Animal Health for the Next Decade. During today’s presentations, Chief Executive Officer Kristin Peck,
   Zoetis Declares New Dividend, Hinting At Undervaluation  2023/05/19 16:51:36 Benzinga
Zoetis (NYSE: ZTS ) shareholders may have a new reference point to be excited about, even after witnessing some favorable developments through the company''s first quarter 2023 announcements. Even after outperforming other peers in the sector, such as Bausch Health Companies (NYSE: BHC ) and Elanco Animal Health (NYSE: ELAN ) by as much as 32% and 75%, respectively, analyst ratings still suggest that Zoetis stock has a double-digit upside potential ceiling from today''s prices. News has broken out regarding JAB''s acquisition of the pet insurance platform Pumpkin. In an attempt to expand its global leadership in the pet insurance industry, JAB''s acquisition indirectly benefitted Zoetis, which still is looking to maintain its minority interest in the platform. A continued commercial partnership and financial interests will no doubt accrue to Zoetis'' financials moving forward. While the transaction terms have not been disclosed, some analysts can derive some valuation given the sixty-five thousand pets insured since Pumpkin''s launch in 2020.
   HANCOCK WHITNEY CORP Buys 2, Sells 3 in 4th Quarter  2023/02/04 00:00:03 GuruFocus
Related Stocks: IVV , AGG , NVDA , THC , ZTS ,
   Do you want to know where to find good stock? Take a look at Zoetis Inc.’s (NYSE:ZTS) Sentiment Analysis  2023/02/03 17:16:00 US Post News
Zoetis Inc. (ZTS)’s stock has witnessed a price declined of -1.71% from the previous close with its current price standing at $168.07. Its current price is -18.14% under its 52-week high of $205.30 and 35.38% more than its 52-week low of $124.15. Based on the past 30-day period, the stock price is -2.15% below the […]
   Zoetis Inc. - Consensus Indicates Potential 25.1% Upside - DirectorsTalk Interviews  2023/01/29 11:34:09 DirectorsTalk
Zoetis Inc. - Consensus Indicates Potential 25.1% Upside
   Zoetis Inc. (NYSE: ZTS) Is Down -0.52% – Is It Capable Of A Rally?  2023/01/25 12:00:00 Stocks Register
Zoetis Inc. (NYSE:ZTS) traded at $165.89 at close of the session on Tuesday, 01/24/23, made a downward move of -0.52% on its previous day’s price. Looking at the stock we see that its previous close was $166.75 and the beta (5Y monthly) reads 0.72 with the day’s price range being $145.20 – $186.73. The company … Zoetis Inc. (NYSE: ZTS) Is Down -0.52% – Is It Capable Of A Rally? Read More »
   Syngene: Timeline for follow-through in Zoetis contract key catalyst to watch  2023/01/25 06:38:47 Moneycontrol
Another growth lever to watch in manufacturing is that of the Mangalore API facility. Here the USFDA approval is expected in H2FY24.

 関連キーワード  (医薬品 米国株 ZTS ゾエティス ZTS )

 twitter  (公式ツイッターやCEOツイッターなど)